178 related articles for article (PubMed ID: 19284381)
1. Pleomorphic lobular carcinoma of the breast: molecular pathology and clinical impact.
Vargas AC; Lakhani SR; Simpson PT
Future Oncol; 2009 Mar; 5(2):233-43. PubMed ID: 19284381
[TBL] [Abstract][Full Text] [Related]
2. Molecular profiling pleomorphic lobular carcinomas of the breast: evidence for a common molecular genetic pathway with classic lobular carcinomas.
Simpson PT; Reis-Filho JS; Lambros MB; Jones C; Steele D; Mackay A; Iravani M; Fenwick K; Dexter T; Jones A; Reid L; Da Silva L; Shin SJ; Hardisson D; Ashworth A; Schmitt FC; Palacios J; Lakhani SR
J Pathol; 2008 Jul; 215(3):231-44. PubMed ID: 18473330
[TBL] [Abstract][Full Text] [Related]
3. Frequent E-cadherin gene inactivation by loss of heterozygosity in pleomorphic lobular carcinoma of the breast.
Palacios J; Sarrió D; García-Macias MC; Bryant B; Sobel ME; Merino MJ
Mod Pathol; 2003 Jul; 16(7):674-8. PubMed ID: 12861063
[TBL] [Abstract][Full Text] [Related]
4. Florid lobular carcinoma in situ: molecular profiling and comparison to classic lobular carcinoma in situ and pleomorphic lobular carcinoma in situ.
Shin SJ; Lal A; De Vries S; Suzuki J; Roy R; Hwang ES; Schnitt SJ; Waldman FM; Chen YY
Hum Pathol; 2013 Oct; 44(10):1998-2009. PubMed ID: 23809857
[TBL] [Abstract][Full Text] [Related]
5. Lobular carcinoma, not only a classic.
Brogi E; Murray MP; Corben AD
Breast J; 2010; 16 Suppl 1():S10-4. PubMed ID: 21050299
[TBL] [Abstract][Full Text] [Related]
6. Pleomorphic lobular carcinoma: a distinctive clinical and molecular breast cancer type.
Monhollen L; Morrison C; Ademuyiwa FO; Chandrasekhar R; Khoury T
Histopathology; 2012 Sep; 61(3):365-77. PubMed ID: 22486370
[TBL] [Abstract][Full Text] [Related]
7. E-cadherin expression in pleomorphic lobular carcinoma: an aid to differentiation from ductal carcinoma.
Wahed A; Connelly J; Reese T
Ann Diagn Pathol; 2002 Dec; 6(6):349-51. PubMed ID: 12478484
[TBL] [Abstract][Full Text] [Related]
8. Pleomorphic lobular carcinoma of the breast: role of comprehensive molecular pathology in characterization of an entity.
Reis-Filho JS; Simpson PT; Jones C; Steele D; Mackay A; Iravani M; Fenwick K; Valgeirsson H; Lambros M; Ashworth A; Palacios J; Schmitt F; Lakhani SR
J Pathol; 2005 Sep; 207(1):1-13. PubMed ID: 15957152
[TBL] [Abstract][Full Text] [Related]
9. Clinical, histopathologic, and biologic features of pleomorphic lobular (ductal-lobular) carcinoma in situ of the breast: a report of 24 cases.
Sneige N; Wang J; Baker BA; Krishnamurthy S; Middleton LP
Mod Pathol; 2002 Oct; 15(10):1044-50. PubMed ID: 12379750
[TBL] [Abstract][Full Text] [Related]
10. Pleomorphic lobular carcinoma in situ (PLCIS) on breast core needle biopsies: clinical significance and immunoprofile.
Chivukula M; Haynik DM; Brufsky A; Carter G; Dabbs DJ
Am J Surg Pathol; 2008 Nov; 32(11):1721-6. PubMed ID: 18769331
[TBL] [Abstract][Full Text] [Related]
11. Genetic and phenotypic characteristics of pleomorphic lobular carcinoma in situ of the breast.
Chen YY; Hwang ES; Roy R; DeVries S; Anderson J; Wa C; Fitzgibbons PL; Jacobs TW; MacGrogan G; Peterse H; Vincent-Salomon A; Tokuyasu T; Schnitt SJ; Waldman FM
Am J Surg Pathol; 2009 Nov; 33(11):1683-94. PubMed ID: 19701073
[TBL] [Abstract][Full Text] [Related]
12. Lobular intraepithelial neoplasia [lobular carcinoma in situ] with comedo-type necrosis: A clinicopathologic study of 18 cases.
Fadare O; Dadmanesh F; Alvarado-Cabrero I; Snyder R; Stephen Mitchell J; Tot T; Wang SA; Ghofrani M; Eusebi V; Martel M; Tavassoli FA
Am J Surg Pathol; 2006 Nov; 30(11):1445-53. PubMed ID: 17063087
[TBL] [Abstract][Full Text] [Related]
13. Pleomorphic lobular carcinoma of the breast: a morphologically and clinically distinct variant of lobular carcinoma.
Butler D; Rosa M
Arch Pathol Lab Med; 2013 Nov; 137(11):1688-92. PubMed ID: 24168512
[TBL] [Abstract][Full Text] [Related]
14. Frequent alterations of HER2 through mutation, amplification, or overexpression in pleomorphic lobular carcinoma of the breast.
Lien HC; Chen YL; Juang YL; Jeng YM
Breast Cancer Res Treat; 2015 Apr; 150(2):447-55. PubMed ID: 25773929
[TBL] [Abstract][Full Text] [Related]
15. Positioning of necrotic lobular intraepithelial neoplasias (LIN, grade 3) within the sequence of breast carcinoma progression.
Boldt V; Stacher E; Halbwedl I; Popper H; Hultschig C; Moinfar F; Ullmann R; Tavassoli FA
Genes Chromosomes Cancer; 2010 May; 49(5):463-70. PubMed ID: 20155841
[TBL] [Abstract][Full Text] [Related]
16. Pleomorphic lobular carcinoma of the breast: clinicopathologic features of 12 cases.
Bentz JS; Yassa N; Clayton F
Mod Pathol; 1998 Sep; 11(9):814-22. PubMed ID: 9758360
[TBL] [Abstract][Full Text] [Related]
17. Pleomorphic lobular carcinoma: morphology, immunohistochemistry, and molecular analysis.
Middleton LP; Palacios DM; Bryant BR; Krebs P; Otis CN; Merino MJ
Am J Surg Pathol; 2000 Dec; 24(12):1650-6. PubMed ID: 11117786
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ.
De Leeuw WJ; Berx G; Vos CB; Peterse JL; Van de Vijver MJ; Litvinov S; Van Roy F; Cornelisse CJ; Cleton-Jansen AM
J Pathol; 1997 Dec; 183(4):404-11. PubMed ID: 9496256
[TBL] [Abstract][Full Text] [Related]
19. Histology and immunophenotype of invasive lobular breast cancer. daily practice and pitfalls.
Varga Z; Mallon E
Breast Dis; 2008-2009; 30():15-9. PubMed ID: 19850991
[TBL] [Abstract][Full Text] [Related]
20. Invasive Pleomorphic Lobular Carcinoma of the Breast: Pathologic, Clinical, and Therapeutic Considerations.
Al-Baimani K; Bazzarelli A; Clemons M; Robertson SJ; Addison C; Arnaout A
Clin Breast Cancer; 2015 Dec; 15(6):421-5. PubMed ID: 26209026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
